Divi’s Laboratories Faces ₹570 Crore Tax Demand
On March 21,2026 company disclosed that it received a draft tax assessment order proposing additions of ₹570.51 crore to its income for FY 2022–23.
Pharma,bribery,drug inspector
JB Pharma Hit with ₹80.81 Lakh GST Penalty
JB Pharma has been hit with a ₹80.81 lakh GST penalty, raising questions about tax compliance in the pharma industry. What led to this action, and should investors be concerned? Here’s a complete breakdown of the case and its implications.
Read MoreMankind Pharma Acquires Roche’s Rivotril Brand to Strengthen CNS Portfolio in India
In a strategic move, Mankind Pharma has acquired the rights of Roche’s Rivotril brand in India. The deal strengthens its presence in CNS therapies and is expected to improve availability and affordability of clonazepam for patients with epilepsy and related conditions.
Read MoreFake Drug Inspector Arrested in Jaipur for Extortion and Job Fraud
A man posing as a Drug Inspector was arrested in Jaipur for extorting chemists using hidden camera evidence and running a fake government job scam. Police are investigating the case as more victims come forward.
Read MoreCorruption Crackdown: Punjab Vigilance Bureau Arrests Drug Inspector for Pharma Bribery
Punjab Vigilance Bureau arrested FDA Drug Inspector Ramandeep Gupta on March 7, 2026, in Bathinda for accepting ₹1 lakh bribe from Radinex Life Sciences’ director. Gupta had sealed the pharma facility (since 2020) and demanded ₹2 lakh monthly to reopen it. VB set a trap after verifying claims, charging him under Prevention of Corruption Act.
Read More
